Qiagen NV | QIA - PE Price to Earnings


Qiagen NV reported 20.54 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Akebia Therapeutics 1.63K 1.6K Dec/2025
argenx SE 32.12 10.9 Mar/2026
Dianthus Therapeutics 3.8 1.53 Sep/2024
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 19.37 7.21 Mar/2026
Moderna 27.22 14.51 Jun/2023
Organon & Co 8.32 4.57 Mar/2026
Qiagen NV 20.54 0.1 Dec/2025
Revvity 30.79 19.08 Mar/2026
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 14.61 4.21 Mar/2026
Xeris Pharmaceuticals 76.05 2.37K Mar/2026